{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Recombinant adeno-associated virus virions for the treatment of lysosomal disorders", "item": "https://www.patentleaderboard.com/patent/6582692"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated virus virions for the treatment of lysosomal disorders

Recombinant adeno-associated virus virions for the treatment of lysosomal disorders

US Patent 6582692 · Granted Jun 24, 2003

Estimated economic value: $1,252,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apparatus and methods for testing visual function and functional vision at varyi2019
Methods of treating anemia using recombinant adeno-associated virus virions2010
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2010
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2007
Adeno associated virus vectors for the treatment of a cardiomyopathy2003
Methods for delivering DNA to the bloodstream using recombinant adeno-associated2002
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2002
Methods of treating disease using recombinant adeno-associated virus virions adm2001
Methods for delivering DNA to the bloodstream using recombinant adeno-associated2001
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme1999
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi1999
Treating anemia using recombinant adeno-associated virus virions comprising an E1998